Phase 2 Severe Asthma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
Moderate to Severe Asthma
Incyte Corporation240 enrolled83 locationsNCT05851443
Recruiting
Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Severe Asthma
Upstream Bio Inc.436 enrolled84 locationsNCT06966479
Recruiting
Phase 2
Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma
Severe Asthma
Oneness Biotech Co., Ltd.20 enrolled9 locationsNCT05018299
Recruiting
Phase 2Phase 3
A Study of CM310 in Subjects With Moderate to Severe Asthma
Moderate to Severe Asthma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.600 enrolled1 locationNCT05761028
Not Yet Recruiting
Phase 2
EPI-12323 for the treatment of symptomatic moderate to severe asthma
Symptomatic moderate to severe asthma
Epigenesis Pharmaceuticals, LLC, USA214 enrolled1 locationACTRN12607000192482